• Twitter
  • Twitter
  • Slideshare
  • logo Amatsigroup

      Preclinical Development Phase 1 Phase 2 Phase 3
COMPOUND APPLICATION TECHNOLOGY Lead
optimisation
Preclinical
development
     
P1301 Parenteral Nanosuspension
P1101 Parenteral
P0403 Parenteral Nanosuspension
P0703 Parenteral Solubility enhancing formulation
P0310 Parenteral Solubility enhancing formulation